	FDA has issued an import ban on Sept. 11, 2015 for products manufactured by Polydrug Laboratories at the company’s Ambernath Industrial Area manufacturing plant in Mumbai, India, due to problems with good manufacturing practices for human and animal drugs.

	The company manufactures anti-hypertensive, anti-fungal, anti-microbial, and muscle relaxant drugs, and distributes products in Mexico, China, Korea, Russia,Taiwan, Singapore, and Ukraine, according to information posted on the 

 reports that Canada and Europe banned products from the same site earlier this year.

Industry News

PharmTech News

Quality Systems

Regulatory Authority Actions

PTSM: Pharmaceutical Technology Sourcing and Management-10-07-2015

Polydrug Laboratories is issued a US import alert, following similar bans in Canada and Europe.